US Patent 11053215 Heterocyclic compounds useful as Pim kinase inhibitors
Patent 11053215 was granted and assigned to Incyte on July, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11053215 Heterocyclic compounds useful as Pim kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.